Lucenteforte, E.; Finocchietti, M.; Addis, A.; Tettamanti, M.; Varano, M.; Parravano, M.; Virgili, G.
Polytherapy and Multimorbidity Pattern of Users of Anti-VEGF Drugs and Dexamethasone for the Treatment of Age-Related Macular Degeneration and other Vascular Retinopathies in Clinical Practice. Pharmaceuticals 2023, 16, 646.
https://doi.org/10.3390/ph16050646
AMA Style
Lucenteforte E, Finocchietti M, Addis A, Tettamanti M, Varano M, Parravano M, Virgili G.
Polytherapy and Multimorbidity Pattern of Users of Anti-VEGF Drugs and Dexamethasone for the Treatment of Age-Related Macular Degeneration and other Vascular Retinopathies in Clinical Practice. Pharmaceuticals. 2023; 16(5):646.
https://doi.org/10.3390/ph16050646
Chicago/Turabian Style
Lucenteforte, Ersilia, Marco Finocchietti, Antonio Addis, Mauro Tettamanti, Monica Varano, Mariacristina Parravano, and Gianni Virgili.
2023. "Polytherapy and Multimorbidity Pattern of Users of Anti-VEGF Drugs and Dexamethasone for the Treatment of Age-Related Macular Degeneration and other Vascular Retinopathies in Clinical Practice" Pharmaceuticals 16, no. 5: 646.
https://doi.org/10.3390/ph16050646
APA Style
Lucenteforte, E., Finocchietti, M., Addis, A., Tettamanti, M., Varano, M., Parravano, M., & Virgili, G.
(2023). Polytherapy and Multimorbidity Pattern of Users of Anti-VEGF Drugs and Dexamethasone for the Treatment of Age-Related Macular Degeneration and other Vascular Retinopathies in Clinical Practice. Pharmaceuticals, 16(5), 646.
https://doi.org/10.3390/ph16050646